NCT03588481招募中不适用
Evaluation of Effectiveness and Safety of DESyne X2 in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Seung-Jung Park7 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年11月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 7
- 主要终点
- Composite event rate
研究概览
简要总结
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 19 and more
- •Intervention with DeSyne X2 drug-eluting coronary stent
- •Agreed with written informed consent form
排除标准
- •Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
- •Life expectancy of 1year and under
- •Cardiac shock
结局指标
主要结局
Composite event rate
时间窗: 1year
Death, non-fatal myocardial infarction, Target Vessel Revascularization
次要结局
- All death(5years)
- Cardiac death(5years)
- Myocardial infarction(5years)
- Composite event of death or myocardial infarction(5years)
- Composite event of cardiac death or myocardial infarction(5years)
- Target Vessel revascularization(5years)
- Target Lesion revascularization(5years)
- Stent thrombosis(5years)
- Stroke(5years)
- Procedural success(3days)
研究者
Seung-Jung Park
Professor, Division of Cardiology, Department of Medicine, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine
Asan Medical Center
研究点 (7)
Loading locations...
相似试验
终止
不适用
DESyne in Routine Clinical PracticeAngioplasty, Transluminal, Percutaneous CoronaryCoronary Artery DiseaseNCT02039713Seung-Jung Park342
招募中
2 期
Evaluation of efficacy and safety of PADYNEX in women with HER2+ metastatic breast cancerIRCT20201223049810N1ano Daru Pajuhan Pardis Company150
进行中（未招募）
2 期
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery LesionsCoronary Artery DiseaseNCT05033964Elixir Medical Corporation200
招募中
不适用
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ StentCoronary Artery DiseaseCardiovascular DiseasesHeart DiseasesCoronary DiseaseMyocardial IschemiaNCT05044273Jung-min Ahn2,000
进行中（未招募）
不适用
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical PracticeCoronary DiseaseCoronary Artery DiseaseNCT03967158Seung-Jung Park2,000